Journal of Hepatology, 2025
AZD2693, a PNPLA3 antisense oligonucleotide, for the treatment of MASH in 148M homozygous participants: two randomized phase I trials

Armisen J., Rauschecker M., Sarv J. et al.

Cell Reports Medicine, 2025
Phase 1/2 trial of brogidirsen: Dual-targeting antisense oligonucleotides for exon 44 skipping in Duchenne muscular dystrophy

Komaki H., Takeshita E., Kunitake K. et al.

Scientific Reports, 2025
The BAMBOO method for correcting batch effects in high throughput proximity extension assays for proteomic studies

Smits H., Delemarre E., Pandit A. et al.

Scientific Reports, 2025
Associations of serum and tissue TIMP1 with host response and survival in colorectal cancer

Kehusmaa A., Tuomisto A., Sirniö P. et al.

British Journal of Dermatology, 2025
High-throughput proteomics identifies inflammatory proteins associated with disease severity and genetic ancestry in patients with hidradenitis suppurativa

Dimitrion P., Krevh R., Veenstra J. et al.

Journal of Infection, 2025
MicroRNA biomarkers and host response pathways in severe pulmonary hemorrhagic syndrome due to leptospirosis: A multi-omics study

Tran P., Limothai U., Dinhuzen J. et al.

Molecular Medicine, 2025
Differential expression of plasma proteins and pathway enrichments in pediatric diabetic ketoacidosis

Spagnolo P., Cela E., Patel M. et al.

Cancer Medicine, 2025
Assessing the Causal Effect of Circulating Protein‐To‐Protein Ratio on the Risk of Morbidity of Hepatocellular Carcinoma

Yue Q., Li X., Wan X. et al.

Frontiers in Oncology, 2025
Machine learning-based identification of proteomic markers in colorectal cancer using UK Biobank data

Radhakrishnan S., Nath D., Russ D. et al.

Brain Communications, 2025
Multi-omics characterization of improved cognitive functions in Parkinson’s disease patients after the combined metabolic activator treatment: a randomized, double-blinded, placebo-controlled phase II trial

Yulug B., Altay O., Li X. et al.

Journal of Proteome Research, 2025
Olink Profiling of Intestinal Tissue Identifies Novel Biomarkers For Colorectal Cancer

Xiao C., Wu H., Long J. et al.

Neurology Neuroimmunology & Neuroinflammation, 2025
Aberrant Complement Activation Is Associated With Structural Brain Damage in Multiple Sclerosis

Oechtering J., Schaedelin S., Stein K. et al.

Diabetes Care, 2025
Large-Scale Plasma Proteomics Improves Prediction of Peripheral Artery Disease in Individuals With Type 2 Diabetes: A Prospective Cohort Study

Yu H., Zhang J., Qian F. et al.

Nature Human Behaviour, 2025
Plasma proteomic signatures of social isolation and loneliness associated with morbidity and mortality

Shen C., Zhang R., Yu J. et al.

Scientific Reports, 2025
Gut microbiota and blood biomarkers in IBD-Related arthritis: insights from mendelian randomization

Yang W., Cui M., Yang P. et al.

Scientific Reports, 2025
Serum inflammation-related proteins in a acute compartment syndrome rat model

Wang T., Cao J., Hou Z. et al.

Diabetes Care, 2025
Proteomic and Metabolomic Signatures in Prediabetes Progressing to Diabetes or Reversing to Normoglycemia Within 1 Year

Barovic M., Hahn J., Heinrich A. et al.

British Journal of Haematology, 2025
Plasma inflammatory and angiogenic protein profiling of patients with sickle cell disease

de Ligt L., Gaartman A., Konté K. et al.

Kidney Medicine, 2025
Serum Cytokine Profile in IgA Nephropathy

Selbach F., Maggiore U., Gentile M. et al.

Metabolism, 2024
Identifying proteins and pathways associated with multimorbidity in 53,026 adults

Chen Y., You J., Guo Y. et al.